Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL272454 | 1.00 | LMNA (0.49) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL272987 | 1.00 | LMNA (0.49) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL272988 | 1.00 | LMNA (0.49) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL272986 | 1.00 | LMNA (0.49) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL4150689 | 0.86 | LMNA (0.49) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL4150683 | 0.86 | LMNA (0.49) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL36902 | 0.82 | LMNA (0.50) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL21838748 | 0.82 | LMNA (0.50) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL28554962 | 0.82 | LMNA (0.50) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 | |
| SCHEMBL273063 | 0.81 | LMNA (0.49) | LMNAALDH1A1CYP3A4CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8133856-B2 | Cis-3,3,5-trimethylcyclohexyl esters | SYMRISE AG (DE) | 2012-03-13 | — | — | US | claimed |
| EP-1648526-B1 | CIS-3,3,5-TRIMETHYLCYCLOHEXYL ESTERS | SYMRISE GMBH & CO KG (DE) | 2009-09-09 | — | — | EP | claimed |
| US-20060211597-A1 | Cis-3,3,5-trimethylcyclohexyl esters | SYMRISE AG (DE) | 2006-09-21 | — | — | US | claimed |
| US-20030068295-A1 | Odor neutralizers | SYMRISE AG (DE) | 2003-04-10 | — | — | US | claimed |
| EP-1239890-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2002-09-18 | — | — | EP | claimed |
| WO-2001043784-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2001-06-21 | — | — | WO | claimed |
| US-4508884-A | COPOLYMER OF UNSATURATED SILICONE ESTER, UNSATURATED ESTER, HYDROP | COOPERVISION, INC. (US) | 1985-04-02 | — | — | US | claimed |
| EP-3661567-A1 | SCENT SWITCH DEVICE | Symrise AG (DE) | 2020-06-10 | — | — | EP | disclosed |
| US-20200171194-A1 | SCENT SWITCH DEVICE | SYMRISE AG (DE) | 2020-06-04 | — | — | US | disclosed |
| WO-2019025007-A1 | SCENT SWITCH DEVICE | SYMRISE AG (DE) | 2019-02-07 | — | — | WO | disclosed |
| US-8133856-B2 | Cis-3,3,5-trimethylcyclohexyl esters | SYMRISE AG (DE) | 2012-03-13 | — | — | US | disclosed |
| EP-2346535-A1 | MALODOR CONTROL SYSTEM | The Procter & Gamble Company (US) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010053891-A1 | MALODOR CONTROL SYSTEM | THE PROCTER & GAMBLE COMPANY (US) | 2010-05-14 | — | — | WO | disclosed |
| US-7157411-B2 | Odor neutralizers | SYMRISE GMBH & CO. KG (DE) | 2007-01-02 | — | — | US | disclosed |
| US-20060211597-A1 | Cis-3,3,5-trimethylcyclohexyl esters | SYMRISE AG (DE) | 2006-09-21 | — | — | US | disclosed |
| EP-1239890-B1 | ODOR NEUTRALIZERS | SYMRISE GMBH & CO KG (DE) | 2004-11-10 | — | — | EP | disclosed |
| US-20030068295-A1 | Odor neutralizers | SYMRISE AG (DE) | 2003-04-10 | — | — | US | disclosed |
| EP-1239890-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2002-09-18 | — | — | EP | disclosed |
| WO-2001043784-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2001-06-21 | — | — | WO | disclosed |
| US-4508884-A | COPOLYMER OF UNSATURATED SILICONE ESTER, UNSATURATED ESTER, HYDROP | COOPERVISION, INC. (US) | 1985-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030068295-A1 | Odor neutralizers | OXER1, OR51E2, OR10J3 | LMNA 3855/4885ALDH1A1 581/4885CYP3A4 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.